(Q31050735)

28 June 2017

1 reference

title

Diagnostic issues in dementia: neuroimaging as a surrogate marker of disease (English)

1 reference

28 June 2017

0 references

1 reference

Gary W Small

1

1 reference

28 June 2017

publication date

1 September 2006

1 reference

Journal of Geriatric Psychiatry and Neurology

28 June 2017

published in

1 reference

28 June 2017

volume

19

1 reference

28 June 2017

issue

3

1 reference

28 June 2017

page(s)

180-185

1 reference

Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study.

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Neuropathologic features of amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Incidence of very mild to severe dementia and Alzheimer's disease in Denmark: the Odense Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Documentation and evaluation of cognitive impairment in elderly primary care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Clinical Value of Neuroimaging in the Diagnosis of Dementia. Sensitivity and Specificity of Regional Cerebral Metabolic and Other Parameters for Early Identification of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Patterns of brain activation in people at risk for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Amyloid probes based on Congo Red distinguish between fibrils comprising different peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291089

21 January 2018

Identifiers

DOI

10.1177/0891988706291089

1 reference

release_q3mxk5mh2jhy7hvxi7k6hp7kje

28 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q3mxk5mh2jhy7hvxi7k6hp7kje

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference